Sept 22 (Reuters) - A federal advisory committee will put off vote on recommending who should get initial limited doses of a potential COVID-19 vaccine, until members learn more about the vaccines that could become available first, the Wall Street Journal reported on Tuesday, citing people familiar the matter.
The Advisory Committee on Immunization Practices, a group of external medical experts that advises the Centers for Disease Control and Prevention, was expected to vote on Tuesday on a plan to prioritize initial doses of any vaccine that proves safe and effective in clinical trials. https://bit.ly/2FUqi5s
The committee may wait until government officials authorize a specific vaccine or vaccines for use before voting on how to give priority to initial doses, according to the report.
There is no approved vaccine for the respiratory illness caused by the novel coronavirus and companies such as Pfizer Inc PFE.N, AstraZeneca Plc AZN.L and Moderna Inc MRNA.O have vaccine candidates in late-stage clinical testing.
CDC did not immediately respond to a Reuters request for comment.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Anil D'Silva)
((email@example.com; +91 8061822700;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.